Classical hodgkin lymphoma as de novo B-cell malignancy after treatment of multiple myeloma in the pre-lenalidomide era

Zago, Manola; Adam, Patrick; Goldschmidt, Hartmut; Fend, Falko; Kanz, Lothar; Weisel, Katja Christina

dc.contributor.author	Zago, Manola
dc.contributor.author	Adam, Patrick
dc.contributor.author	Fend, Falko
dc.contributor.author	Kanz, Lothar
dc.contributor.author	Weisel, Katja
dc.date.accessioned	2017-04-06T06:55:12Z
dc.date.available	2017-04-06T06:55:12Z
dc.date.issued	2014
dc.identifier.issn	2152-2650
dc.identifier.uri	http://hdl.handle.net/10900/75723
dc.language.iso	en	de_DE
dc.publisher	New York: Elsevier	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.clml.2013.07.101	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Classical hodgkin lymphoma as de novo B-cell malignancy after treatment of multiple myeloma in the pre-lenalidomide era	de_DE
dc.type	Article	de_DE
utue.publikation.seiten	e7-e11	de_DE
utue.personen.roh	Zago, Manola
utue.personen.roh	Adam, Patrick
utue.personen.roh	Goldschmidt, Hartmut
utue.personen.roh	Fend, Falko
utue.personen.roh	Kanz, Lothar
utue.personen.roh	Weisel, Katja Christina
dcterms.isPartOf.ZSTitelID	Clinical lymphoma, myeloma & leukemia	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	14	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE